| dc.contributor.author | Pandey, A K | |
| dc.contributor.author | Sharma, Rashmi | |
| dc.contributor.author | Shivahare, Rahul | |
| dc.contributor.author | Arora, Ashish | |
| dc.contributor.author | Rastogi, Neeraj | |
| dc.contributor.author | Gupta, Suman | |
| dc.contributor.author | Chauhan, P M S | |
| dc.date.accessioned | 2013-04-04T11:04:06Z | |
| dc.date.available | 2013-04-04T11:04:06Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Journal of Organic Chemistry, 2013, 78 (4), 1534–1546 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/1039 | |
| dc.description.abstract | The first protocol for the synthesis of perspicamide A and related diverse analogues has been developed from economical and readily available starting materials. Furthermore, a few synthesized analogues 24a, 24b, 24c, 24d and 24l exhibited potent activity against Leishmania donovani with IC50 values ranging from 3.75 to 10.37 µM and a selectivity index (SI) ranging from 9.58 to 53.12 which is better compared to the standard drug Miltefosine (IC50 12.4 µM and SI 4.1). | en |
| dc.format.extent | 320531 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | CDRI communication no. 8378 | en |
| dc.subject | Perspicamide A | en |
| dc.subject | Leishmania donovani | en |
| dc.subject | Standard drug Miltefosine | en |
| dc.title | Synthesis of Perspicamide A and Related Diverse Analogues: Their Bio-evaluation as Potent Antileishmanial Agents | en |
| dc.type | Article | en |